Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients

Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients

Background Patient‐derived organoid (PDO) models are highly valuable and have potentially widespread clinical applications. However, limited information is available regarding organoid models of non‐small cell lung cancer (NSCLC). This study aimed to characterize the consistency between primary tumo...

Full description

Bibliographic Details
Main Authors: Jing‐Hua Chen, Xiang‐Peng Chu, Jia‐Tao Zhang, Qiang Nie, Wen‐Fang Tang, Jian Su, Hong‐Hong Yan, Hong‐Ping Zheng, Ze‐Xin Chen, Xin Chen, Meng‐Meng Song, Xin Yi, Pan‐Song Li, Yan‐Fang Guan, Gang Li, Chu‐Xia Deng, Rafael Rosell, Yi‐Long Wu, Wen‐Zhao Zhong
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Thoracic Cancer
Subjects:
Consistency analysis
drug screening
non‐small cell lung cancer
patient‐derived organoid
whole exome sequencing
Online Access:https://doi.org/10.1111/1759-7714.13542

Internet

https://doi.org/10.1111/1759-7714.13542

Similar Items